Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status

Many patients with asthma remain symptomatic despite treatment with inhaled corticosteroids (ICS) with or without long-acting β2-agonists (LABAs). Tiotropium add-on to ICS plus a LABA has been shown to improve lung function and reduce exacerbation risk in patients with symptomatic asthma.

Source: Respiratory Medicine CME - June 12, 2016 Category: Respiratory Medicine Authors: Huib A.M. Kerstjens, Petra Moroni-Zentgraf, Donald P. Tashkin, Ronald Dahl, Pierluigi Paggiaro, Mark Vandewalker, Hendrik Schmidt, Michael Engel, Eric D. Bateman Source Type: research